Dr. Sheema Imran, MD

Dr. Imran practices at Raritan Bay Medical Center in Perth Amboy, New Jersey, part of Hackensack Meridian Health.

Dr. Imran's NPI, 1427462019, was assigned on June 11, 2014. Dr. Imran holds New Jersey license 25MA10273900.

Dr. Imran's primary practice is Raritan Bay Medical Center, at 530 New Brunswick Ave, Perth Amboy, NJ 08861 in Middlesex County. The practice phone is (732) 324-5000. Dr. Imran also practices at Raritan Bay Medical Center, 531 New Brunswick Ave, Perth Amboy, NJ 08861.

Dr. Imran's primary practice is Raritan Bay Medical Center in Perth Amboy, New Jersey, part of Hackensack Meridian Health. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Imran to 1 more physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Imran practices, 2 sites in all. Vendor and product names are available with a free account.

Geriatric psychiatry is Dr. Imran's primary specialty in the NPI Registry, under taxonomy code 2084P0805X. Dr. Imran is licensed in New Jersey.

CMS data shows 1,363 Medicare services from Dr. Imran across 5 procedure codes in 2024, for 156 Medicare patients. Medicare paid $93,987 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 156 Medicare patients who saw Dr. Imran in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have anxiety, and 75% have depression. 42% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Imran's median patient age at 46, with 39% women.

In 2024, Dr. Imran wrote 948 Medicare Part D claims for 139 patients. 76% of them were for generic drugs. CMS names the drug for 523 of them, across 26 drugs with 11 or more claims each, at $162,342 in total drug cost. In 2023, CMS named 533 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Imran for performance year 2024, reported through an alternative payment model (APM). Dr. Imran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Imran as offering telehealth.

Dmand AI links 1 paper to Dr. Imran in 2014. Dr. Imran's most frequent co-authors are Barry Reisberg, MD and Aninditha Soman Vengassery, MD.

CMS Open Payments shows 52 general payments to Dr. Imran from 10 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $221.